Quinolone resistance mechanisms in pneumococci

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Quinolones are essential for treating respiratory infections due to their efficacy against Streptococcus pneumoniae.
• The emergence of quinolone-resistant pneumococcal strains poses a significant threat to public health.
• Understanding resistance mechanisms is crucial for developing effective treatment strategies.

Purpose of the Study:

• To investigate the mechanisms underlying quinolone resistance in Streptococcus pneumoniae.
• To identify the genetic mutations associated with resistance to newer "respiratory quinolones".

Main Methods:

• Analysis of pneumococcal isolates exhibiting reduced susceptibility to respiratory quinolones.
• Identification of mutations in the genes encoding DNA gyrase and topoisomerase IV.
• Assessment of the role of drug efflux in quinolone resistance.

Main Results:

• Quinolone resistance in S. pneumoniae is primarily caused by mutations in DNA gyrase and topoisomerase IV.
• Some isolates show resistance due to drug efflux mechanisms.
• Strains with mutations in both enzymes are commonly observed in resistant isolates.
• Resistance has emerged in pneumococcal strains with characteristics favorable for widespread transmission.

Conclusions:

• Mutations in key bacterial enzymes are the primary drivers of quinolone resistance in S. pneumoniae.
• The spread of resistant strains, particularly those adapted for transmission, is a serious concern.
• Continued surveillance and research are necessary to combat the growing threat of quinolone resistance in respiratory pathogens.